EMPG: Empro Earnings growth forecast for next year

Brandmark of empro.my (EMPG)

Warehouse chain optimization eliminates supply delays, confirming a shift in the consensus estimate for net profit growth; 0.00 captures the magnitude of this parameter. Empro Group Inc (EMPG) builds its business foundation on nano-formulas for skin regeneration and robust R&D potential. Financial stability relies on sales in Malaysia, although overall profitability depends on the expansion of the dealer network across Southeast Asia.

Empro (EMPG): Expected earnings per share growth for next year from 07/03/2025 to 10/25/2025

empro.my - analytical breakdowns and key metrics (EMPG)

- price and consensus price forecast:
Price Chart Empro|EMPG - Broker Consensus Forecast
- market capitalization information:
Market Capitalization Empro Group|EMPG - Total Enterprise Value
- book capitalization indicators:
Net Assets per Single Share Empro Group|EMPG - Company Net Assets|Market Value to Book Value Ratio empro.my|EMPG - Total Asset Value of Company
- issuer credit burden and liquidity indicators:
Debt to Equity Empro Group Inc|EMPG - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Empro Group|EMPG - Company Cumulative Debt|Debt to Book Value Empro Group|EMPG - Company Long-Term Loans and Borrowings|Company Short-Term Debts Empro Group|Quick Liquidity empro.my
- net income and valuation ratios data:
EMPG - Final Profit|Expected Profit Empro Group Inc|EMPG - Market Cap to Earnings|Projected Price to Earnings Empro Group Inc|EMPG - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Empro Group|EMPG - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months Empro Group|EMPG - Earnings per share for the trailing year|Quarterly EPS earnings growth empro.my|EMPG - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Empro Group Inc
- sales volume and revenue indicators:
EMPG - Company Sales Volume|Projected Sales Volume Empro|EMPG - Market Cap to Revenue|Forward P/S Multiple Empro Group
Fundamental company analysis:Empro
Core merchandise of Empro Group

This metric is calculated as the percentage difference between the projected and current net earnings per share. It reflects the aggregate expectations of experts regarding the growth rates of business profitability over a short-term horizon. For Empro Group Inc (EMPG), the effectiveness of diversifying Asian supplies of dermatological raw materials directly determines the stability of the consensus regarding the change in earnings per share for the following year.

Competitor analysis for Empro Group Inc

Net earnings per share growth forecast for next year Krystal Corp|Projected earnings per share growth rate for next year APGE (Apogee Corp)|Earnings growth forecast for next year ARQT|VCEL - Expected net earnings per share growth next year|Net earnings per share growth forecast for next year Oruka Therapeutics ORKA|SMTI - Expected earnings per share growth for next year|DBVT - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year SLSN|journeymedicalcorp.com (DERM) - Net earnings per share growth forecast for next year|fortebiorx.com - Expected earnings per share trend next year|Net earnings per share growth forecast for next year Sol-Gel Technologies Ltd.|Expected net earnings per share growth next year Revive Pro Care AXIL|Expected earnings per share growth for next year MDCX (Medicus Pharma Limited)|VRCA (verrica.com) - Expected earnings per share trend next year|Earnings growth forecast for next year HOTH (Hoth Therapeutics)|Net earnings per one share growth forecast for next year Biofrontera, Inc.|VYNE - Net earnings per share growth forecast for next year|Expected earnings per share trend next year SNOA (Sonoma Pharmaceuticals)|quoinpharma.com (QNRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Azitra Corporation (AZTR)|Expected earnings per share growth for next year DRMA|Earnings growth forecast for next year elevaiskincare.com|Net earnings per share growth forecast for next year Revance Therapeutics, Inc. (RVNC)